Sabinsa Corporation of Australia was represented by Vladimir Badmaev, M.D., Ph.D., Vice President, Scientific and Medical Affairs, at the CHC’s (Complementary Healthcare Council) Sponsors’ Obligations Conference held recently in Sydney, October 31st - November 1st. The diverse range of speakers and content at the Conference focused on the theme of Evidence in use and practice of complementary medicine in Australia and other countries worldwide. The CHC organized the event to provided information and education on matters affecting the dynamically growing industry of complementary medicine in Australia. Dr. Vladimir Badmaev presented paper titled “Evidence Gathering Methods: Curcuminoids from Curcuma longa in the fight against cancer and age related disorders”. The presentation summarized several years experience of Sabinsa Corporation in preclinical and clinical studies of the phenolic compounds curcuminoids from Curcuma longa in cooperation with MD Anderson Cancer Center, Houston TX, and the UCLA School of Medicine and Dentistry, Los Angeles CA...